IRadimed Corporation logo

IRadimed Corporation

IRMD | NASDAQ
Chart Builder DCF Calculator
$85.15
+$2.69 (+3.26%)
Sep 22, 2026, 2:42 PM ET · Market open

Company Profile

IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.

Key Executives

Name Position
Roger E. Susi Founder, Chairman, Chief Executive Officer & President
John F. Glenn Chief Financial Officer & Corporate Secretary
Chris Williamson Executive Vice President of Continuous Improvement & Information Technology
Jeff Chiprin Chief Commercial Officer
Lynn Neuhardt Vice President of Research & Development
Matt Garner Controller
Randy Waddell Vice President of Worldwide Sales & Marketing

Latest SEC Filings

Date Type Title
Aug 18, 2026 8-K/A [Amend] Current Report
Jul 31, 2026 10-Q Quarterly Report
Jul 31, 2026 8-K Current Report
Jul 28, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Jun 24, 2026 8-K Current Report
Jun 23, 2026 4 Filing
Jun 04, 2026 4 Filing
Jun 02, 2026 4 Filing
May 28, 2026 4 Filing
May 20, 2026 4 Filing
View All SEC Filings
IRadimed Corporation
IRadimed Corporation logo
Country United States
IPO Date Jul 15, 2014
Industry Medical - Devices
Sector Healthcare
Employees 166
CEO Roger E. Susi

Contact Details

1025 Willa Springs Drive Orlando, Florida 32826 United States

Stock Details

Ticker Symbol IRMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001325618
CUSIP Number 46266A109
ISIN Number US46266A1097
SIC Code 3841

© 2026 bestshares.com. All rights reserved.